{"id":642650,"date":"2017-08-20T03:57:22","date_gmt":"2017-08-20T03:57:22","guid":{"rendered":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/"},"modified":"2017-08-20T03:57:22","modified_gmt":"2017-08-20T03:57:22","slug":"hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally","status":"publish","type":"post","link":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/","title":{"rendered":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally"},"content":{"rendered":"<p><strong>REGIONAL- Jordanian med manufacturer Hikma <\/strong><a href=\"http:\/\/www.prnewswire.co.uk\/news-releases\/hikma-announces-expanded-licensing-agreement-with-takeda-for-new-products-in-the-middle-east-and-north-640864963.html\"><strong>signed an agreement<\/strong><\/a><strong> with Takeda <\/strong><strong>to expand licensing and distribution.<\/strong> The agreement allows Hikma to have the right to register, manufacture, market, distribute, and sell four of Takeda's leading primary care products in 17 markets in the MENA region. \u201cThe agreement, however, does not include the Egyptian market for Alogloptin. Hikma also has exclusive rights to manufacture and commercialise Takeda's Dexlansoprozole in its MENA markets, with the exception of Saudi Arabia, the UAE and Egypt.\u201d Hikma had acquired Egypt\u2019s EIMC United <a href=\"https:\/\/enterprise.press\/stories\/2016\/03\/31\/the-world-will-have-1-7-mn-fewer-bankers-within-the-next-decade\/\">in early 2016<\/a> and had announced plans to open an EGP 500 mn cancer drug manufacturing plant <a href=\"https:\/\/enterprise.press\/stories\/2016\/10\/30\/hikma-to-establish-cancer-drug-manufactory-factory-in-egypt\/\">later during the year<\/a>. Separately, <a href=\"https:\/\/ftalphaville.ft.com\/2017\/08\/17\/2192446\/opening-quote-hikma-proves-that-generic-copy-is-hard-to-churn-out\/\">The FT\u2019s Matthew Vincent<\/a> says Hikma\u2019s below forecast 1H2017 result shows the challenges for generic medication makers. CEO Said Darwazah <a href=\"http:\/\/www.iii.co.uk\/alliance-news\/1502967790459565200-3\/extra-hikma-shares-hit-four-year-low-as-it-trims-guidance-once-again\">blamed part of the drop<\/a> in earnings on the EGP devaluation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>REGIONAL- Jordanian med manufacturer Hikma signed an agreement with Takeda to expand licensing and distribution. The agreement allows Hikma to have the right to register, manufacture, market, distribute, and sell four of Takeda's leading primary care products in 17 markets in the MENA region. \u201cThe agreement, however, does not include the Egyptian market for Alogloptin. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"single-feature.php","format":"standard","meta":{"_acf_changed":false,"newspack_ads_suppress_ads":false,"newspack_popups_has_disabled_popups":false,"newspack_sponsor_sponsorship_scope":"","newspack_sponsor_native_byline_display":"inherit","newspack_sponsor_native_category_display":"inherit","newspack_sponsor_underwriter_style":"inherit","newspack_sponsor_underwriter_placement":"inherit","ep_exclude_from_search":false,"_primary_brand":0,"newspack_featured_image_position":"","newspack_post_subtitle":"","newspack_article_summary_title":"Overview:","newspack_article_summary":"","newspack_hide_updated_date":false,"newspack_show_updated_date":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[8572],"tags":[72,2380],"brand":[],"newspack_spnsrs_tax":[],"class_list":["post-642650","post","type-post","status-publish","format-standard","hentry","category-speed-round","tag-enterpriseam","tag-speed-round","wpautop","entry"],"acf":{"mongo_id":"0c017f94-dbc0-4b28-a1e8-1148e6e2a404","order":"0","is_powered_by":true,"section_story_id":"16ec267d-41b7-41b4-87ba-409188d26b0f","story_type":"1","photo_url":"","photo_position":"above","related_issue":[642626],"teaser":"","voice_url":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Hikma signs agreement to sell Takeda\u2019s primary care products regionally - EnterpriseAM Egypt<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hikma signs agreement to sell Takeda\u2019s primary care products regionally\" \/>\n<meta property=\"og:description\" content=\"REGIONAL- Jordanian med manufacturer Hikma signed an agreement with Takeda to expand licensing and distribution. The agreement allows Hikma to have the right to register, manufacture, market, distribute, and sell four of Takeda&#039;s leading primary care products in 17 markets in the MENA region. \u201cThe agreement, however, does not include the Egyptian market for Alogloptin. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\" \/>\n<meta property=\"og:site_name\" content=\"EnterpriseAM Egypt\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-20T03:57:22+00:00\" \/>\n<meta name=\"author\" content=\"enterpriseam admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"enterpriseam admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\"},\"author\":{\"name\":\"enterpriseam admin\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\"},\"headline\":\"Hikma signs agreement to sell Takeda\u2019s primary care products regionally\",\"datePublished\":\"2017-08-20T03:57:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\"},\"wordCount\":152,\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"keywords\":[\"EnterpriseAM\",\"SPEED ROUND\"],\"articleSection\":[\"Speed Round\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\",\"name\":\"Hikma signs agreement to sell Takeda\u2019s primary care products regionally - EnterpriseAM Egypt\",\"isPartOf\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\"},\"datePublished\":\"2017-08-20T03:57:22+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/enterpriseam.com\/egypt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hikma signs agreement to sell Takeda\u2019s primary care products regionally\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#website\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"name\":\"EnterpriseAM\",\"description\":\"The State of the Nation\",\"publisher\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#organization\",\"name\":\"EnterpriseAM\",\"url\":\"https:\/\/enterpriseam.com\/egypt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ent.news\/internal\/240894.svg\",\"contentUrl\":\"https:\/\/ent.news\/internal\/240894.svg\",\"caption\":\"EnterpriseAM\"},\"image\":{\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d\",\"name\":\"enterpriseam admin\",\"sameAs\":[\"http:\/\/enterpriseam.testing.projectsarea.com\"],\"url\":\"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally - EnterpriseAM Egypt","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/","og_locale":"en_US","og_type":"article","og_title":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally","og_description":"REGIONAL- Jordanian med manufacturer Hikma signed an agreement with Takeda to expand licensing and distribution. The agreement allows Hikma to have the right to register, manufacture, market, distribute, and sell four of Takeda's leading primary care products in 17 markets in the MENA region. \u201cThe agreement, however, does not include the Egyptian market for Alogloptin. [&hellip;]","og_url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/","og_site_name":"EnterpriseAM Egypt","article_published_time":"2017-08-20T03:57:22+00:00","author":"enterpriseam admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"enterpriseam admin","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/#article","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/"},"author":{"name":"enterpriseam admin","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d"},"headline":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally","datePublished":"2017-08-20T03:57:22+00:00","mainEntityOfPage":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/"},"wordCount":152,"publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"keywords":["EnterpriseAM","SPEED ROUND"],"articleSection":["Speed Round"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/","url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/","name":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally - EnterpriseAM Egypt","isPartOf":{"@id":"https:\/\/enterpriseam.com\/egypt\/#website"},"datePublished":"2017-08-20T03:57:22+00:00","breadcrumb":{"@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/20\/hikma-signs-agreement-to-sell-takedas-primary-care-products-regionally\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/enterpriseam.com\/egypt\/"},{"@type":"ListItem","position":2,"name":"Hikma signs agreement to sell Takeda\u2019s primary care products regionally"}]},{"@type":"WebSite","@id":"https:\/\/enterpriseam.com\/egypt\/#website","url":"https:\/\/enterpriseam.com\/egypt\/","name":"EnterpriseAM","description":"The State of the Nation","publisher":{"@id":"https:\/\/enterpriseam.com\/egypt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/enterpriseam.com\/egypt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/enterpriseam.com\/egypt\/#organization","name":"EnterpriseAM","url":"https:\/\/enterpriseam.com\/egypt\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/","url":"https:\/\/ent.news\/internal\/240894.svg","contentUrl":"https:\/\/ent.news\/internal\/240894.svg","caption":"EnterpriseAM"},"image":{"@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/enterpriseam.com\/egypt\/#\/schema\/person\/ca597032db7e4db868359c123cec256d","name":"enterpriseam admin","sameAs":["http:\/\/enterpriseam.testing.projectsarea.com"],"url":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"}]}},"featured_image_src":null,"featured_image_src_square":null,"author_info":{"display_name":"enterpriseam admin","author_link":"https:\/\/enterpriseam.com\/egypt\/author\/enterpriseam\/"},"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":565019,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-is-staying-put-for-now\/","url_meta":{"origin":642650,"position":0},"title":"GSK is staying put \u2014 for now","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"GSK puts Egypt exit on the backburner: GlaxoSmithKline has shelved plans to sell its units in Egypt and Tunisia following the breakdown of talks with UK-listed Hikma Pharma, the company said in a disclosure (pdf) to the EGX today. The pharma giant initially wanted to sell its entire 91.2% stake\u2026","rel":"","context":"In &quot;SPEED ROUND: M&amp;A WATCH&quot;","block_context":{"text":"SPEED ROUND: M&amp;A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round-ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":560791,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/03\/14\/gsk-hikma-end-acquisition-talks\/","url_meta":{"origin":642650,"position":1},"title":"GSK, Hikma end acquisition talks","author":"enterpriseam admin","date":"14 March 2021","format":false,"excerpt":"Hikma Pharma won\u2019t be acquiring GlaxoSmithKline\u2019s Egypt unit: GSK and Hikma Pharma have agreed to end talks over a takeover bid submitted in January by the UK-listed company that would have seen it acquire a majority stake in GSK\u2019s Egypt arm, both companies said (here and here \u2013 pdfs) on\u2026","rel":"","context":"In &quot;M&amp;A WATCH&quot;","block_context":{"text":"M&amp;A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/3\/185.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559931,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/09\/gsk-only-has-eyes-for-hikma\/","url_meta":{"origin":642650,"position":2},"title":"GSK only has eyes for Hikma","author":"enterpriseam admin","date":"9 February 2021","format":false,"excerpt":"GlaxoSmithKline (GSK) has rejected separate takeover bids from Rameda and Acdima for its Egypt arm, focusing instead on talks with Hikma Pharma, according to regulatory filings (here and here \u2014 pdfs). GSK said the decision is meant to minimize disruption to the business and save time and resources that would\u2026","rel":"","context":"In &quot;M&amp;A WATCH&quot;","block_context":{"text":"M&amp;A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/153.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":559722,"url":"https:\/\/enterpriseam.com\/egypt\/2021\/02\/02\/a-bidding-war-for-gsks-egyptian-arm\/","url_meta":{"origin":642650,"position":3},"title":"A bidding war for GSK\u2019s Egyptian arm?","author":"enterpriseam admin","date":"2 February 2021","format":false,"excerpt":"Acdima may have just touched off a bidding war for GlaxoSmithKline's Egypt business, according to a regulatory filing (pdf) yesterday, less than a week after the global player revealed that Hikma was interested in a transaction. Acdima, a pharma industry investor focused on Arab countries, plans to make an offer\u2026","rel":"","context":"In &quot;M&amp;A WATCH&quot;","block_context":{"text":"M&amp;A WATCH","link":"https:\/\/enterpriseam.com\/egypt\/category\/ma-watch\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/2021\/2\/37.jpg?fit=%2C&ssl=1&resize=350%2C200","width":350,"height":200},"classes":[]},{"id":642709,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/08\/21\/hikma-gets-unwanted-attention-for-us-price-hikes\/","url_meta":{"origin":642650,"position":4},"title":"Hikma gets unwanted attention for US price hikes","author":"enterpriseam admin","date":"21 August 2017","format":false,"excerpt":"REGIONAL\u2013 Not the type of attention you want in the international press: Hikma is indeed London-listed, but the Jordan-based maker of meds is one of the quietest global success stories to have emerged from our corner of the world. Now, the company is under fire after a Financial Times investigation\u2026","rel":"","context":"In &quot;Speed Round&quot;","block_context":{"text":"Speed Round","link":"https:\/\/enterpriseam.com\/egypt\/category\/speed-round\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]},{"id":639560,"url":"https:\/\/enterpriseam.com\/egypt\/2017\/10\/31\/new-ras-al-hikma-city-in-the-works\/","url_meta":{"origin":642650,"position":5},"title":"New Ras Al Hikma City in the works","author":"enterpriseam admin","date":"31 October 2017","format":false,"excerpt":"The government is looking to build a New Ras Al Hikma City on the North Coast,sources tell Al Borsa. The 150 mn sqm city will be centered on tourism and is intended to complement the new Al Alamein City. Planned projects include resorts and an international marina to serve the\u2026","rel":"","context":"In &quot;Tourism&quot;","block_context":{"text":"Tourism","link":"https:\/\/enterpriseam.com\/egypt\/category\/data\/tourism\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/ent.news\/internal\/536550.png?resize=350%2C200&ssl=1","width":350,"height":200},"classes":[]}],"_links":{"self":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/642650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/comments?post=642650"}],"version-history":[{"count":0,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/posts\/642650\/revisions"}],"acf:post":[{"embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/issue\/642626"}],"wp:attachment":[{"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/media?parent=642650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/categories?post=642650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/tags?post=642650"},{"taxonomy":"brand","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/brand?post=642650"},{"taxonomy":"newspack_spnsrs_tax","embeddable":true,"href":"https:\/\/enterpriseam.com\/egypt\/wp-json\/wp\/v2\/newspack_spnsrs_tax?post=642650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}